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Abstract: Traditional methods for phenotyping skeletal muscle (e.g., immunohistochemistry) are
labor-intensive and ill-suited to multixplex analysis, i.e., assays must be performed in a series.
Addressing these concerns represents a largely unmet research need but more comprehensive parallel
analysis of myofibrillar proteins could advance knowledge regarding age- and activity-dependent
changes in human muscle. We report a label-free, semi-automated and time efficient LC-MS proteomic
workflow for phenotyping the myofibrillar proteome. Application of this workflow in old and young
as well as trained and untrained human skeletal muscle yielded several novel observations that were
subsequently verified by multiple reaction monitoring (MRM). We report novel data demonstrating
that human ageing is associated with lesser myosin light chain 1 content and greater myosin light
chain 3 content, consistent with an age-related reduction in type II muscle fibers. We also disambiguate
conflicting data regarding myosin regulatory light chain, revealing that age-related changes in this
protein more closely reflect physical activity status than ageing per se. This finding reinforces the need
to control for physical activity levels when investigating the natural process of ageing. Taken together,
our data confirm and extend knowledge regarding age- and activity-related phenotypes. In addition,
the MRM transitions described here provide a methodological platform that can be fine-tuned to
suite multiple research needs and thus advance myofibrillar phenotyping.
Keywords: ageing; human skeletal muscle; myosin heavy chain; myosin light chain; selective
reaction monitoring
1. Introduction
Musculoskeletal ageing is characterized by age-related muscle fiber atrophy, as a corollary of motor
unit (MU) loss [1]. Each MU comprises a presynaptic motor neuron and a postsynaptic population
of mono-innervated skeletal muscle fibers [2]. MUs are, typically but not always [3], defined by
uniform skeletal muscle fiber isoform (Type I, Type II) content [4]. Type II MUs are preferentially
lost with age, owing to failed re-innervation [2]. Functionally, type II MU loss underpins age-related
phenotypical alterations (e.g., reduced skeletal muscle power [5]), owing to the distinct contractile
and metabolic properties associated with each fiber type (reviewed in [4,6]). Therefore, classification
Proteomes 2016, 4, 15; doi:10.3390/proteomes4020015 www.mdpi.com/journal/proteomes
Proteomes 2016, 4, 15 2 of 15
of skeletal muscle fiber type can provide insight into the nature of the phenotypical alterations that
define musculoskeletal ageing [7].
Traditional biochemical and histochemical approaches to characterizing skeletal muscle phenotype
involve assessment of metabolic enzyme activity (e.g., citrate synthase activity) and myosin heavy
chain (MyHC) isoform content and/or ATPase activity [8,9]. Such approaches have revealed that
musculoskeletal ageing is associated with reduced citric acid cycle and electron transport chain
subunit activity and content [10,11], although this is modifiable by physical activity levels [1]. Ageing
is also associated with reduced MyHCIIa and MyHCIIx expression, consistent with type II MU
loss [7]. Unfortunately, the techniques used to collect the aforementioned data require relatively
large amounts of sample and are ill-suited to multiplex analysis so typically just a few proteins are
studied in isolation [9,12–14] and in a serial rather than parallel manner. The latter is a particular
concern because metabolic and contractile differences can be uncoupled [12,15]. Resultantly, metabolic
differences can exist despite similar MyHC isoform content [12]. The age-related appearance of hybrid
skeletal muscle fibers that co-express multiple MyHC isoforms further complicates this issue [16].
The collective limitations of traditional biochemical and histochemical approaches preclude complete
characterization of age and physical activity level phenotypes in skeletal muscle.
Proteomic approaches to characterizing skeletal muscle phenotype confer several important
advantages, notably the capacity to analyze multiple proteins in a parallel and un-biased
manner [17–20]. Consequently, proteomic research has advanced understanding of the phenotypical
changes associated with musculoskeletal ageing [7,10,21–25]. For example, Gelfi et al. [7] reported
myosin regulatory light chain (MLRS) content was lower in older compared with younger individuals,
which may contribute to age-related contractile dysfunction [26]. Nevertheless, existing literature is
broadly limited by two major caveats. First, the confounding influence of activity levels has seldom
been standardized or controlled in human studies. For instance, lower MLRS isoform content of elderly
individuals [7] could reflect reduced physical activity rather than a direct effect of ageing per se. Second,
inconsistencies exist between proteomic studies in model species (e.g., rodents) compared with humans.
For example, in contrast to humans, commonly used rodent models are inbred and rodents express a
fast type MyHCII isoform (Type II b [9,15]), which is not present in human locomotive muscles.
Two-dimensional gel electrophoresis (2DGE) has been commonly employed in muscle proteomic
investigations but this technique has widely acknowledged [12,19,21,27–29] technical limitations. In an
effort to overcome some of the technical issues associated with 2DGE, we have used a high-performance
liquid chromatography coupled mass spectrometry (LC-MS) that affords time-efficient (180 min per
sample), automated and quantitative analysis of skeletal muscle samples [12]. Recent application
of this approach identified heart-type fatty acid binding protein as a novel biomarker of aerobic
capacity in both rodent and human skeletal muscle samples [12]; confirming the utility of this novel
phenotypical approach. We reasoned that application of LC-MS to the myofibrillar fraction may
advance phenotyping by enabling the measurement of isoform expression and splice variation of the
myofibrillar proteome. Accordingly, the aims of the present study were to: (1) quantify differences in
MyHC content using traditional denaturing gel electrophoresis methods; then (2) mine the myofibrillar
proteome using LC-MS/MS; and (3) investigate differences between muscle samples of young and
elderly adults using LC-MS label-free profiling. In addition, trained and untrained participants were
included in each age group to further dissect the influence of physical activity levels on phenotypical
biomarkers of ageing [10,11,30]. Finally, we used multiple reaction monitoring to verify discoveries
generated by LC-MS profiling.
2. Results
2.1. MyHC Isoform Analysis
Denaturing gel electrophoresis conditions were optimized using a pooled standard (10 µg protein
from each individual, n = 24). MyHC isoforms (MyHCI, MyHCIIa and MyHCIIx) were successfully
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resolved into three distinct bands (Figure 1). MyHC isoform content (MyHCI: 52.4% ˘ 1.7%, MyHCIIa:
38.4% ˘ 3.9% and MyHCIIx: 9.2% ˘ 2.2%) was consistent with previous literature [31]. Satisfied
with the optimization of our electrophoresis protocol, we next analyzed individual samples (Figure 2).
Endurance trained individuals typically exhibit greater Type I fiber content and thus lower Type IIa
and Type IIx content compared with untrained individuals, as a function of genetic and environmental
factors [3,6,15]. Consistent with this, percentage MyHCI and MyHCIIa levels were greater and lower,
respectively, in trained compared with untrained participants (Table 1), irrespective of age [7]. Type IIa
and Type IIx muscle fibers are preferentially lost with age as a consequence of failed re-innervation [2].
Accordingly, we report MyHCIIa levels were lower in older compared with younger participants,
regardless of training status (Table 1). In addition, MyHCIIa and MyHCIIx levels were lower in the old
trained (OT) compared with young trained (YT) group. Taken together, our MyHC isoform content
analysis confirms known age- and physical activity-related phenotypes.
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Figure 1. Separation of MyHC isoforms in human skeletal muscle using denaturing gel electrophoresis: 
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of interest, into distinct bands (IIx, IIa, I) based in differences in migration (pooled standard, n = 24); and 
(C) images of lanes aligned with the area of interest. 
 
Figure 2. Influence of age and activity levels on MyHC isoform content in human skeletal muscle. 
Representative image of gel lanes from young trained (YT), young untrained (YU), old trained (OT) 
and old untrained (OU) individuals with clear separation of MyHC isoforms into distinct bands. 
  
Figure 1. Separation of yHC isofor s in hu an skeletal uscle using denaturing gel electrophoresis:
( ) representative image of gel lanes showing separation of MyHC isoforms; (B) density plot showing
area of interest, into distinct bands (IIx, IIa, I) based in differences in migration (pooled standard,
n = 24); and (C) images of lanes aligned with the area of interest.
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Table 1. Quantitative analysis of MyHC isoform content by group.
Band YT YU OT OU Effect of Agein Trained
Effect of Age
in Untrained
IIx (%) 9.0 ˘ 8.3 13.8 ˘ 13.5 0.2 ˘ 0.4 9.5 ˘ 13.1 98% lower 31% lower
Iia (%) 35.6 ˘ 14.2 50.2 ˘ 15.1 21.7 ˘ 13.8 * 30.0 ˘ 20.7 40% lower 40% lower
I (%) 55.4 ˘ 27.8 36.0 ˘ 12.1 78.1 ˘ 14.2 * 60.5 ˘ 30.1 41% higher 68% higher
* Denotes significant difference (p ď 0.05) from YU.
2.2. LC-MS-MS Mining of the Myofibrillar Proteome
Denaturing gel electrophoresis-based MyHC isoform staining approaches are laborious and
time consuming, i.e., typically requiring electrophoresis at a stable temperature for ~15 h. Therefore,
we investigated whether mass spectrometry-based analyses could provide a more comprehensive
and time efficient analysis of muscle phenotype. We first mined the myofibrillar fraction (pooled
standard) before quantifying phenotypical differences in individual samples. LC-MS/MS mining of the
myofibrillar fraction of a pooled standard identified 47 proteins (M and SD: Mascot Score 5295 ˘ 8146;
Sequence coverage: 34.6% ˘ 20.4%; Number of peptides: 10 ˘ 17; Table 2), which represents the
most abundant myofibrillar proteins [28], including the actin-myosin complex, troponins, myosin
light chains and tropomyosins (Figure 3). This demonstrates the potential utility of LC-MS profiling
to identify and study multiple isoforms of common myofibrillar proteins in a semi-automated and
time-efficient manner.
Proteomes 2016, 4, 2 6 of 14 
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Table 2. List of myofibrillar proteins identified by LC-MS-MS in a pooled standard.
Accession Protein Name Score SC (%) Peptides MW pI
MYH3 Myosin-3 12,997 20 1 223.8 5.5
MYH13 Myosin-13 5824 14 1 223.5 5.4
MYH7 Myosin-7 31,073 52 71 223.0 5.5
MYH1 Myosin-1 27,777 41 11 223.0 5.5
MYH2 Myosin-2 36,676 51 94 222.9 5.5
MYH4 Myosin-4 18,379 28 1 222.9 5.6
MYOM2 Myomesin-2 116 9 5 164.8 5.8
MYPC1 Myosin-binding protein C, slow type 763 17 14 128.2 5.7
ACTN2 Alpha-actinin-2 5705 45 31 103.8 5.2
LDB3 LIM domain-binding protein 3 1259 18 9 77.1 9.4
ALBU Serum albumin precursor 1689 41 20 69.3 5.9
K2C1 Keratin, type II cytoskeletal 1 171 10 6 66.0 8.8
PDLI5 PDZ and LIM domain protein 5 135 15 4 63.9 9.6
K1C10 Keratin, type I cytoskeletal 116 6 3 58.8 5.0
ATPB ATP synthase subunit beta, mitochondrial 261 21 6 56.5 5.1
DESM Desmin 1778 39 15 53.5 5.1
VIME Vimentin 424 14 2 52.6 4.9
ENOB Beta-enolase 324 47 4 46.9 8.6
CASQ1 Calsequestrin-1 1718 11 2 44.5 3.9
KCRM Creatine kinase M-type 5182 43 1 43.1 6.9
ACTS Actin, alpha skeletal muscle 12,390 63 23 42.0 5.1
ACTB Actin, cytoplasmic 1 6353 30 1 41.7 5.2
ALDOA Fructose-bisphosphate aldolase A 1159 41.8 9 39.4 9.2
ALDOC Fructose-biphosphate aldolase C 102 18 1 39.4 6.5
FHL1 Four and a half LIM domains protein 1 398 14 3 36.2 10.5
G3P Glyceraldehyde-3-phosphate dehydrogenase 599 38 7 36.0 9.3
TNNT1 Troponin T, slow skeletal muscle 1119 26 6 32.9 5.8
TPM2 Tropomyosin beta- chain 7878 38 13 32.8 4.5
TPM3 Tropomyosin alpha-3 chain 6338 44 7 32.8 4.5
TPM1 Tropomyosin alpha- 1 chain 7298 44 11 32.7 4.5
TNNT3 Troponin T, fast skeletal muscle 1262 24 6 31.8 5.6
MYOZ1 Myozenin-1 599 51 7 31.7 9.3
CAH3 Carbonic anhydrase 3 760 38 6 29.5 7.1
MYL6B Myosin light chain 6B 152 15 1 22.7 5.5
MYL3 Myosin light chain 3 4390 68 10 21.9 4.9
TNNI1 Troponin I, slow skeletal muscle 1043 29 5 21.7 10.3
TNNI2 Troponin I, fast skeletal muscle 901 14 3 21.3 9.6
MYL1 Myosin light chain 1/3, skeletal muscle 8270 8 15 21.1 4.8
MLRS Myosin regulatory light chain 2, skeletal muscle 7121 72 2 19 4.7
MLRV Myosin regulatory light chain 2, venticular/cardiac 3186 72 11 18.8 4.7
TNNC1 Troponin C, slow skeletal and cardiac 261 9 2 18.4 3.9
TNNC2 Troponin C, skeletal muscle 2162 33 4 18.1 3.9
MYG Myoglobin 3163 55 8 17.2 7.9
MYL6 Myosin light polypeptide 6 1402 30 2 16.9 4.4
HBB Hemoglobin subunit beta 11,403 88 12 16 6.9
HBD Hemoglobin subunit delta 4206 69 2 16 9.1
HBA Hemoglobin subunit alpha 2586 53 6 15.2 9.4
2.3. Differences in the Myofibrillar Proteome Due to Age or Habitual Levels of Physical Activity
Label-free LC-MS profiling matched 265 peptides across samples from young untrained (YU),
young trained (YT), old untrained (OU) and old trained (OT) individuals. Statistical analysis of these
data discovered 19 peptides from six proteins exhibited age- and physical activity-related differences
(Table 3). Six peptides were specific for different isoforms of myosin essential or regulatory light chains,
whereas peptides belonging to MyHC could not be used to unambiguously identify specific isoforms.
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Table 3. Label-free LC-MS-MS profiling of the myofibrillar faction of individual samples.
Accession Retention Time: Mass/Charge Ratio
p-Value
Age Training Age ˆ Training
Sequence
ACTS
40.1 min: 644.31 m/z 0.552 0.289 0.02 GILTLK
98.9 min: 895.86 m/z 0.024 0.315 0.336 SYELPDGQVITIGNER
44.7 min: 1162.47 m/z 0.043 0.537 0.678 EITALAPSTMK
MLRS
83.4 min: 652.64 m/z 0.159 0.029 0.05 VAPEEHPTLLTEAPLNPK
103.8 min: 1524.61 m/z 0.117 0.03 0.2 FLEELLTTQCDR
32.1 min: 1173.43 m/z 0.06 0.026 0.399 DGIIDKEDLR
MYH
104.4 min: 1319.51 m/z 0.045 0.046 0.465 GADPEDVITGAFK
117.6 min: 895.91 m/z 0.026 0.096 0.211 NAYEESLDQLETLK
21.9 min: 1004.37 m/z 0.268 0.348 0.041 ELEEISER
144.6 min: 1893.88 m/z 0.004 0.051 0.051 LLSTLFANYAGADAPIEK
67.1 min: 1507.59 m/z 0.015 0.275 0.302 LTYTQQLEDLKR
21.5 min: 1272.36 m/z 0.015 0.51 0.87 TLEDQMNEHR
MYL1
20.0 min: 1411.48 m/z 0.876 0.832 0.027 ELTYQTEEDRK
17.8 min: 1482.51 m/z 0.108 0.555 0.033 KVQHELDEAEER
119.4 min: 1010.42 m/z 0.508 0.022 0.444 EAFLLFDR
MYL3
116.4 min: 1542.60 m/z 0.001 0.841 0.798 DQATYEDFVEGLR
22.9 min: 1524.60 m/z 0.03 0.917 0.662 AAPAPAPPPEPERPK
TPM 68.8 min: 1243.50 m/z 0.04 0.574 0.63 IQLVEEELDR
Peptide data from label-free profiling were analyzed by two-way analysis of variance. Data
represent statistical output (p values) of the main comparisons for age (young versus old) or training
status (trained versus untrained) or the interaction between age and training status for each peptide.
The retention time and mass-to-charge ratio of each peptide is reported and proteins were identified
from the SwissProt database: skeletal muscle actin (ACTS), skeletal muscle myosin regulatory light
chain (MLRS), myosin heavy chain (MYH), myosin essential light chain 1 (MYL1), myosin essential
light chain 3 (MYL3) and tropomyosin (TPM).
2.4. Confirmation of Age- and Activity-Related Differences in Myosin Light and Regulatory Chain Isoforms
Using Selective Reaction Monitoring
Label-free LC-MS profiling of the human myofibrillar proteome discovered MLRS, MYL1 and
MYL3 abundance may significantly differ as a function of age and physical activity. To verify these
discoveries, we further performed selective reaction monitoring of isoform specific tryptic peptides [12].
The utility of this approach was first confirmed by programming the mass spectrometer to selectively
monitor single isoform-specific transitions, for example the doubly charged precursor ion (600.82 m/z)
corresponding to ITLSQVDVLR of human MYL1 and the selective transition to the y6 Fragment ion
(658.3 m/z) illustrated in Figure 4. Thereafter, we used multiple reaction monitoring (MRM) to quantify
(Table 4) the following isoform-specific transitions: 505.7 Ñ 550.2 (MYL1), 600.8 Ñ 658.3 (MYL1),
771.7Ñ 835.4 (MYL1), 498.2Ñ 759.4 (MYL3), 600.2Ñ 735.4 (MLRS) and 762.8Ñ 780.2 (MLRS).
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Figure 4. Selective reaction monitoring of MYL1 transition 600.8 Ñ 658.3. Parent ion MS spectra
(A) and annotated MS/MS spectra (B) of the doubly-charged peptide ITLSQVGDVLR spanning
residues 70–80 of MYL1_HUMAN. Selective monitoring (C) of the y6 ion (m/z 658.3) was used and
relative abundance was measured as area under the curv of the extracted ion (m/z 600.8 Ñ 658.3)
chromatogram (D).
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Table 4. Verification of myosin light chain abundances by multiple reaction monitoring.
Transition Young Old Age (p Value) Trained Untrained Activity(p-Value)
MYL1 (771.7Ñ 835.4) 1372 ˘ 669 796 ˘ 280 0.06 868 ˘ 388 1343 ˘ 684 0.024
MYL1 (600.8Ñ 658.3) 2790 ˘ 1309 1682 ˘ 640 0.007 1761 ˘ 848 2806 ˘ 1252 0.013
MYL1 (505.7Ñ 550.2) 3829 ˘ 2133 1764 ˘ 1187 0.007 2014 ˘ 1515 3744 ˘ 2149 0.025
MYL1 total 2081 ˘ 977 1239 ˘ 450 0.006 1315 ˘ 614 2075 ˘ 953 0.014
MLY3 (498.2Ñ 759.4) 3579 ˘ 1682 6353 ˘ 3347 0.021 5881 ˘ 3140 3867 ˘ 2403 0.083
MYL3:MYL1 ratio 1.72 5.13 4.47 1.86
MLRS (660.2Ñ 735.4) 1029 ˘ 436 740 ˘ 399 0.108 701 ˘ 379 1097 ˘ 410 0.029
MLRS (762.8Ñ 780.2) 2101 ˘ 1135 1236 ˘ 834 0.048 1251 ˘ 904 2164 ˘ 1080 0.039
MLRS total 1565 ˘ 778 988 ˘ 591 0.055 976 ˘ 630 1630 ˘ 725 0.031
Data are presented as mean ˘ standard deviation (SD) of the area under the curve for each isoform specific
transition. Main effect p values are presented for statistical analysis by age (young and old) and activity (trained
and untrained) level.
MYL1: MRM analysis of MYL1 revealed that each isoform specific transition was significantly
(p ď 0.05) greater in young compared with old participants, irrespective of training status (Table 4).
Accordingly, mean MYL1 isoform abundance was significantly greater (p ď 0.05) in young compared
with old participants. MYL1, is principally expressed in fast twitch fibers [32] and MYL1 abundance
was significantly less in OT (p = 0.004) and OU (p = 0.045) groups compared with YU group (Table 5).
There was also a trend (p = 0.63) towards greater MY1 abundance in YU compared with YT. Altogether,
MYL1 data are consistent with greater fast twitch fiber abundance in trained compared with untrained
participants and an age-related loss of fast twitch muscle fibers in skeletal muscle [6,7,15,21].
Table 5. MRM transition area under the curve by group.
Isform Specific Transition YT YU OT OU
MYL1 (771.7Ñ 835.4) 1034 ˘ 482 1779 ˘ 672 703 ˘ 181 * 907 ˘ 356 *
MYL1 (600.8Ñ 658.3) 5777 ˘ 2532 5707 ˘ 7583 5457 ˘ 5430 * 8436 ˘ 8908
MYL1 (505.7Ñ 550.2) 2829 ˘ 1822 4829 ˘ 2072 1199 ˘ 373 * 2441 ˘ 1515
MYL1 Average 1568 ˘ 801 2698 ˘ 459 1062 ˘ 186 * 1451 ˘ 600 *
MYL3 (498.2Ñ 759.4) 4529 ˘ 1478 2438 ˘ 1166 7233 ˘ 3889 * 5296 ˘ 2556
MYL3:MYL1 ratio 2.89 0.90 6.81 3.65
MLRS (762.8Ñ 780.2) 1632 ˘ 116 2571 ˘ 980 869 ˘ 321 * 1675 ˘ 1081
MLRS (660.2Ñ 735.4) 829 ˘ 450 1229 ˘ 345 573 ˘ 273 * 939 ˘ 46
MLRS Average 1231 ˘ 794 1900 ˘ 658 721 ˘ 295 * 1307 ˘ 730
Data are presented as mean ˘ standard deviation (SD) of the area under the curve for each isoform specific
transition. * Denotes significant difference (p ď 0.05) from YU group.
MYL3: MYL3, which is enriched in slow skeletal muscle fibers [13,33], displayed the reverse
profile being significantly (p = 0.021) greater in older compared with younger participants, with a
trend (p = 0.083) towards higher levels in trained compared with untrained participants (Table 4).
MYL3 abundance was significantly (p = 0.038) less in YU compared with OT. MYL3 abundance was
not different (p ě 0.05) between YT and OT groups (Table 5). MYL3 data are, therefore, consistent with
the greater type I fiber content in older compared with younger skeletal muscle [6,7,15,21], driven by
lower levels in YU compared with OT.
MLRS: Mean MLRS (also referred to MLC2-f) content was significantly (p = 0.031) greater in
untrained compared with trained participants, with a trend (p = 0.055) towards lower MLRS content in
older compared with younger participants (Table 4). Mean MLRS abundance (Table 5) was significantly
(p = 0.030) greater in YU compared with OT, whereas mean MLRS abundance did not differ (p ě 0.05)
between YU and YT. Therefore, our MLRS data are broadly consistent with greater fast twitch fiber
content in untrained compared with trained participants [6,7,15,21].
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Collectively, our data demonstrate that isoform specific myosin light chain transitions are useful
phenotypical biomarkers of age and activity related phenomena in human skeletal muscle.
3. Discussion
We used traditional biochemical analysis of MyHC isoforms to confirm age-related differences
in human muscle phenotype and further demonstrate the effect of habitual activity on these data.
We expand on our previous work [12,28], by using label-free LC-MS profiling to phenotype the human
myofibrillar proteome. We resolved 47 myofibrillar proteins without prior orthogonal separation,
which is consistent with the well-documented high-abundance of a small number of contractile proteins
in skeletal muscle [17,19,20]. Indeed, just ten contractile and metabolic proteins account for over half
of the total protein content in skeletal muscle [29,30]. LC-MS profiling detected significant differences
in the abundance of peptides belonging to essential and regulatory myosin light chains between
young and elderly individuals that were either sedentary or undertook regular exercise training.
To verify these findings, we performed MRM of selected isoform-specific peptides using a condensed
LC gradient with a sample turn-around of 40 min. In addition to verifying novel information regarding
age-related differences in myosin light chain abundances, future researchers are able to capitalize on
these findings and also perform rapid, semi-automated and parallel profiling of muscle proteins using
our reported transitions.
Consistent with previous literature [7,21,31], MyHCIIa abundance, a marker of Type IIa fiber
content, was less in older compared with younger individuals, regardless of training status. Indeed,
MyHCIIx, a marker of Type IIx content, was almost completely absent in the OT group. MyHCIIa
and MyHC IIx phenotypes are likely to be associated with the age-related preferential loss of Type II
MU [2,34]. The molecular sequelae underpinning Type II MU loss are unclear but this phenomenon may
be driven by aberrant repulsive axonal guidance (e.g., Semaphorin 3A) mediated denervation [34–36].
Irrespective of age, trained participants displayed greater MyHCI and lesser MyHCIIa abundance
compared with untrained participants. This is consistent with greater Type I and lesser Type IIa
fiber content in endurance-trained individuals owing to genetic and environmental factors [6,15].
Whilst our cross-sectional design precludes causative analysis [10], MyHC data are consistent with
known age- and activity-related phenotypes [7,21,25]. Our ability to confirm existing paradigms of
age- and activity-related MyHC phenotypes using traditional analysis meant we could largely exclude
the possibility that discoveries made by LC-MS profiling were entirely specific to the population of
individuals and instead can be discussed alongside existing literature.
Label-free profiling overcomes many of the technical limitations associated with 1D and 2D gel
electrophoresis and could significantly advance phenotyping of skeletal muscle. Nonetheless, LC-MS
analysis based solely on intensities of parent ion masses can be confounded by interference from
unrelated peptides that share analogous retention times and mass-to-charge ratios [12]. With this
limitation in mind, we sought to verify the age- and activity-related differences in actin, myosin,
tropomyosin, MLRS, MYL1 and MYL3 using multiple reaction monitoring (MRM; reviewed in [37])
This technique selectively monitors and quantifies the intensity of daughter ions from known parent
ions (termed transitions [12]), which greatly enhances the specificity of the analysis. We previously
used MRM to confirm that heart-type fatty acid protein was more abundant in rodents artificially
selected for higher aerobic capacity compared with lower aerobic capacity [12], affirming the utility
of this approach in skeletal muscle. Application of MRM to the myofibrillar fraction presented a
significant analytical challenge owing to high myofibrillar protein sequence homology. For example,
MYL1 and MYL3 share 72.6% sequence identify. Consequently, only isoform specific transitions in
selected proteins were analyzed.
Myosin essential (MYL1, MYL3) and regulatory (MLRS) light chains were selected for MRM
analysis owing to their essential role in regulating contractile velocity [38] and prior reports of
differential expression in old compared with young skeletal muscle [7,22]. MYL1 and MLRS
are predominately, but not exclusively [39,40], expressed in fast twitch muscle, whereas MYL3
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is predominately expressed in slow twitch muscle [13,24]. Using known age and activity related
phenotypes as a conceptual framework [2,3,6,21,34], it could be predicted, a priori, that: (1) MYL1 and
MLRS content should be greater; and (2) MYL3 content should be lesser in the skeletal muscle
of elderly compared to young adults. The prediction for MLRS is complicated by conflicting
reports of an age-related decrease in MLRS in humans [7] against a drastic increase in MLRS that
demarcates the onset of senescence in rodent skeletal muscle [26]. Whilst this could be related
to interspecies differences [41], it could equally be attributable to a failure to control for physical
activity status particularly in human studies [1,42]. We reasoned that the latter was more likely
owing to a recent report documenting lower MRLS content in trained compared with recreational
runners [43]. In support of this, we report novel evidence that age-related changes in MLRS abundance
could easily be confounded by the physical activity status of the participants. Specifically, MLRS
differed as a function of training status and the trend towards differential age-related expression
was owing to significantly greater levels in YU compared with OT, but not YT compared with OT.
This observation warrants further mechanistic exploration. Future reports may wish to extend our
observations by comparing the relative abundance and phosphorylation status of each of the fast and
slow regulatory isoforms.
We also report novel data identifying that MYL1 and MYL3 content is lesser and greater,
respectively, in the muscle of old compared with younger adults. As a consequence, the ratio between
MYL3 and MYL1 is dramatically different between young, elderly, trained and untrained humans
(Tables 4 and 5). Our findings are the first of their kind rendering comparison with previous literature
difficult. This notwithstanding, MYL1, MYL3 and MLRS data confirm our MyHC analysis and are
consistent with the notion that ageing is accompanied by preferential Type II MU loss [2,34]. It will,
however, be important to confirm this observation with longitudinal studies that permit greater
mechanistic insight; as one cannot rule out the possibility that innate fiber type differences between our
groups underpinned our observations and not age or physical activity status per se. Such caveats should
be viewed globally; that is, they are generic to the research field, being unrestricted to the present
study owing to the difficulties associated with conducting longitudinal studies of human ageing.
MRM affords semi-automated, rapid and quantitative phenotyping [12,37] and the potential
wider application of this approach has not escaped our attention. Future investigators may wish
to use our data as a resource to perform isoform specific MRM analysis of myosin light chain
content; thus, obviating the limitations of traditional methods of muscle phenotyping. In the future,
this approach could be further extended by spiking samples with stable isotope-labeled peptides to
provide quantitative analysis of human samples.
4. Materials and Methods
4.1. Participants
Ethical approval was granted from the Liverpool John Moores University Ethics Committee
and the present study adhered to the declaration of Helsinki. After providing written informed
consent, 12 younger (18–30 years) and 12 older (ě55 years) Caucasian males participated and were
segregated according to training history to yield four experimental groups: young trained (YT, n = 6),
young untrained (YU, n = 6), old trained (OT, n = 6) and old untrained (OU, n = 6). Trained participants
were competitive amateur cyclists that had habitually completed at least five endurance sessions per
week. Untrained participants did not participate in systematic endurance training and completed
ě3 exercise sessions per week. Basic participant anthropometrical and physiological characteristics
have been reported previously [42,44].
4.2. Muscle Biopsies
After the administration of a local anesthetic (0.5% Marcaine), muscle biopsies were obtained
from the Vastus Lateralis using a Bard Monopty disposable biopsy instrument (12 cm ˆ 10 cm gauge,
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Bard Monopty Systems, Tempe, AZ, USA). Muscle samples were immediately snap frozen in liquid
nitrogen and stored at ´80 ˝C until further analysis.
4.3. MyHC Isoform Staining
Approximately 20–30 mg of frozen muscle tissue was ground to powder and homogenized in
120 µL of ice cold lysis buffer supplemented with phosphatase and protease inhibitors (25 mM Tris/HCl
(pH 7.4), 50 mM NaF, 100 mM NaCl, 5 mM EGTA, 1 mM EDTA, 10 mM Na-Pyrophosphatase, 1 mM
Na3VO4, 0.27 M sucrose, 1% Triton X-100, 0.1% 2-mercaptoethanol). Homogenates were centrifuged
at 1000 g for 10 min at 4 ˝C. The resultant pellet (myofibrillar protein) was re-suspended in 1% SDS
buffer and boiled at 95 ˝C for 5 min. Protein content was determined using a Bradford assay [45].
Samples (10 µL equivalent to 0.5 µg¨µL´1 protein) were separated by molecular weight using an
8% denaturing gel electrophoresis protocol (see [29,30]). Samples were electrophoresed on ice for 15 h
at 280 V. Polyacrylamide gels were washed (ddH2O) and stained with Coomassie blue, as previously
described [46,47]. Bands were quantified by densitometry analysis on T120 (Total lab., Newcastle upon
Tyne, UK) software.
4.4. Label Free Liquid Chromatography Coupled Mass Spectrometry (LC-MS)
The myofibrillar faction was prepared for in-solution digest by precipitating supernatants in
5 volumes of acetone, re-suspending in 0.1% (w/v) Rapigest SF (Waters; Milford, MA, USA) and
50 mM ammonium bicarbonate before incubation at 80 ˝C for 15 min. Pellets were reduced with
DTT (final concentration 1 mM) at 60 ˝C for 15 min in the dark before being alkylated with 5 mM
at 4 ˝C for 30 min. Sequence grade trypsin (Promega, Madison, WI, USA) was added at a protein
ratio of 1:50 and digestion allowed to proceed at 37 ˝C overnight. Digestion was terminated by 2 µL
concentrated TFA addition. Tryptic peptide solutions were cleared by centrifugation at 13,000 g for
15 min at room temperature.
Label free LC-MS analysis was performed on a quadrupole-high capacity ion-trap (HCT Ultra ETD
II; Bruker Daltonics, Bremen, Germany) coupled to an online electrospray ionization and nano-flow
HPLC system (Ultimate 3000; Dionex, Sunnyvale, CA, USA). Consistent with previous work [12],
tryptic digests (0.8 µg/µL) were diluted 1:10 in 0.1% formic acid (FA) solution. Samples (5 µL) were
loaded onto a pre-column (Agilent Technologies Ltd., Santa Carla, CA, USA) and separated on Zorbax
300SB C18 3.5 µm, 15 cm ˆ 75 µm analytical reverse phase column (Agilent Technologies Ltd.) at
a flow rate of 300 nL¨min´1 using a non-linear gradient rising to 40% acetonitrile 0.1% FA over
160 min. Mass spectra for LC-MS profiling were recorded between 200 m/z and 2500 m/z using
standard enhanced mode (8100 (m/z)/s). Equivalent data-dependent tandem mass spectrometry
(MS/MS) spectra were collected from triplicate analysis of a pooled standard. MS/MS spectra of
collision-induced dissociation fragment ions were recorded for the 5 most abundant precursors from
each survey scan (350 to 1600 m/z).
Profile analysis (defined by two attributes: age and physical activity status) was used to
calculate peptide regulation ratios. Peptides that significantly differed between group attributes
were determined (Profile Analysis Version 4.0; Bruker Daltonics, Bremen, Germany). LC-MS/MS data
were combined to identify proteins with a Swiss-Prot database restricted to “Human” on a locally
implemented Mascot (www.matrixscience.com) server (version 2.2.03). Peptide/protein identifications
were linked to the peptide regulation ratios determined in Profile Analysis and protein regulation
ratios were calculated from peptide regulation ratios.
4.5. Selective Reaction Monitoring (SRM)
SRM [37] was used to verify and quantify differences in myosin light chain 1 (MYL1), myosin light
chain 3 (MYL3) and myosin regulatory light chain 2 (MLRS) isoform specific tryptic digests and
their associated precursor and product fragment ions. Samples were separated using a linear
chromatographic gradient rising to 40% acetonitrile and 0.1% FA over 15 min. Samples were analyzed
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in duplicate and in a randomized order. Transitions of m/z 498–759 were monitored for MYL3,
m/z 771–835 and m/z 600–658 for MYL1, m/z 660–735 and m/z 762–780 for MLRS.
4.6. Statistical Analysis
A two-way ANOVA was employed to determine the influence of age (i.e., young vs. old)
and physical activity (i.e., trained vs. untrained) levels on outcome variables (e.g., MyHC content).
To determine where significant differences occurred, significant main effects of age and activity levels
were further explored with post-hoc Bonferroni tests. An α value of p ď 0.05 was used for all tests.
Statistical analysis was performed on the Statistical Package for Social Sciences (SPSS, version 17.0,
SPSS Inc.: Chicago, IL, USA). Data are presented as Mean and SD (˘).
5. Conclusions
We used an advanced analytical workflow to perform phenotypic profiling of the human
myofibrillar proteome. In doing so we discovered and verified novel differences in the abundance
of essential myosin light chains MYL1 and MYL3 associated with age. Moreover, by studying
well-defined populations of physically-active and sedentary individuals we were able to resolve
previously conflicting data regarding differences in regulatory myosin light chain content in the muscle
of young and elderly adults.
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